Related Experiment Video
Updated: Aug 8, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
Published on: June 6, 2017
Unmasking the redundancy between Cdk1 and Cdk2 at G2 phase in human cancer cell lines
Lawrence L'Italien1, Marcel Tanudji, Loren Russell
1Schering-Plough Biopharma, Palo Alto, California 94304, USA.
Abstract:
A series of studies published in 2003 has challenged the essentiality of Cdk2. A recently published work indicates that cyclin E-Cdk1 compensates for Cdk2's function at G1/S transition in Cdk2(-/-) Mefs. In this study, we uncovered a redundant mechanism between Cdk1 and Cdk2 at G2 in multiple cancer cell lines. When either Cdk2 or Cdk1 is ablated using RNAi, there were complex shifts of cyclin A towards its reciprocal partner, i.e., when Cdk2 is ablated, cyclin A redistributes to Cdk1; when Cdk1 is ablated, cyclin A forms more abundant complexes with Cdk2. Further, cyclin B redistributes to Cdk2 upon Cdk1 knockdown. These redistributions bring about increased kinase activities of corresponding complexes. Elimination of the compensatory mechanism by knockdown of both Cdk1 and Cdk2 using RNAi reveals phenotypes at G2 phase. The results suggest that the redistributed complexes contribute to the cyclin B-Cdk1 activation when either Cdk1 or Cdk2 alone is ablated and this redundancy masks Cdk2's role when Cdk2 is singly ablated. It is also worth noting that the predominant G2 arrest described here, unlike those Cdk1-Cdk2 double ablated Mefs, raises a question of whether different Cdk activities are required for G1/S or G2/M progression in normal vs. cancer cells.
Insights
Cyclin-dependent kinases (CDK1) and CDK2 show functional redundancy in cancer cells. Ablating one kinase leads to compensatory shifts, masking essential roles and impacting cell cycle progression.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Previous studies questioned the essentiality of Cyclin-dependent kinase 2 (Cdk2).
- Recent findings suggest Cdk1 compensates for Cdk2 during the G1/S transition in specific cell types.
Purpose of the Study:
- To investigate potential redundant mechanisms between Cdk1 and Cdk2 in cancer cell lines.
- To understand the functional consequences of ablating Cdk1 or Cdk2 on cell cycle progression.
Main Methods:
- Utilized RNA interference (RNAi) to selectively knockdown Cdk1 and Cdk2 in multiple cancer cell lines.
- Analyzed cyclin A and cyclin B redistribution patterns upon Cdk1 or Cdk2 ablation.
- Assessed kinase activities of resulting cyclin-CDK complexes.
Main Results:
- Observed complex redistribution of cyclin A to its reciprocal CDK partner upon single kinase ablation.
- Demonstrated cyclin B redistribution to Cdk2 following Cdk1 knockdown, enhancing kinase activity.
- Simultaneous knockdown of both Cdk1 and Cdk2 revealed significant G2 phase cell cycle arrest.
Conclusions:
- A redundant mechanism between Cdk1 and Cdk2 exists at the G2 phase in cancer cells.
- This redundancy masks the essential role of Cdk2 when singly ablated, contributing to cell cycle progression.
- The distinct G2 arrest observed suggests differential CDK activity requirements for cell cycle progression in normal versus cancer cells.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

